Establishment Labs Holdings (ESTA) Cash from Investing Activities (2017 - 2026)

Establishment Labs Holdings' (ESTA) quarterly Cash from Investing Activities came in at -$2.0 million in Q1 2026, down 46.71% year-on-year from -$3.7 million in Q1 2025, and down 18.0% quarter-over-quarter from -$1.7 million in Q4 2025.

Establishment Labs Holdings (ESTA) Cash from Investing Activities (2017 - 2026) Analysis & Trends

Establishment Labs Holdings' Cash from Investing Activities history runs 10 years deep, the most recent figure standing at -$2.0 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 46.71% year-over-year to -$2.0 million in Q1 2026; TTM through Mar 2026 was -$7.7 million, a 25.86% increase from a year earlier, with the FY2025 full-year figure at -$7.0 million, up 54.98% from the prior year.
  • Cash from Investing Activities slipped to -$2.0 million in Q1 2026 per ESTA's latest filing, from -$1.7 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$1.3 million in Q1 2025 and bottomed at -$13.8 million in Q2 2022.
  • The 5-year median for Cash from Investing Activities is -$4.4 million (2024), against an average of -$4.9 million.
  • Across the five-year window, Cash from Investing Activities slumped 1380.6% in 2022 and jumped 79.84% in 2025, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$10.4 million in 2022, then jumped by 55.7% to -$4.6 million in 2023, then surged by 60.63% to -$1.8 million in 2024, then rose by 8.69% to -$1.7 million in 2025, then slipped by 18.0% to -$2.0 million in 2026.
  • Per Business Quant, the three latest ESTA Cash from Investing Activities figures stand at -$2.0 million (Q1 2026), -$1.7 million (Q4 2025), and -$2.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 Establishment Labs Holdings 2.75 Bn 2.68 Bn 42.34 Mn -1.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.96 Mn
Mar 31, 2026 -1.96 Mn
Dec 31, 2025 -1.66 Mn
Dec 31, 2025 -1.66 Mn
Sep 30, 2025 -1.96 Mn
Sep 30, 2025 -1.96 Mn
Jun 30, 2025 -2.07 Mn
Jun 30, 2025 -2.07 Mn
Mar 31, 2025 -1.34 Mn
Mar 31, 2025 -1.34 Mn
Dec 31, 2024 -1.82 Mn
Dec 31, 2024 -1.82 Mn
Sep 30, 2024 -2.77 Mn
Sep 30, 2024 -2.77 Mn
Jun 30, 2024 -4.40 Mn
Jun 30, 2024 -4.40 Mn
Mar 31, 2024 -6.63 Mn
Mar 31, 2024 -6.63 Mn
Dec 31, 2023 -4.62 Mn
Dec 31, 2023 -4.62 Mn